Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy

Simple item page
dc.contributor.authorJackson, Ronalden_AU
dc.contributor.authorWorley, Matthewen_AU
dc.contributor.authorTrivedi, Shubhanshien_AU
dc.contributor.authorRanasinghe, Charanien_AU
dc.date.accessioned2015-12-13T22:33:17Z
dc.date.issued2014
dc.date.updated2015-12-11T09:15:35Z
dc.description.abstractWe have established that the efficacy of a heterologous poxvirus vectored HIV vaccine, fowlpox virus (FPV)-HIV gag/pol prime followed by attenuated vaccinia virus (VV)-HIV gag/pol booster immunisation, is strongly influenced by the cytokine milieu at the
dc.identifier.issn0264-410X
dc.identifier.urihttp://hdl.handle.net/1885/75958
dc.publisherElsevier
dc.sourceVaccine
dc.titleNovel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy
dc.typeJournal article
local.bibliographicCitation.issue43
local.bibliographicCitation.lastpage5714
local.bibliographicCitation.startpage5703
local.contributor.affiliationJackson, Ronald, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationWorley, Matthew, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationTrivedi, Shubhanshi, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationRanasinghe, Charani, College of Medicine, Biology and Environment, ANU
local.contributor.authoruidJackson, Ronald, u1576711
local.contributor.authoruidWorley, Matthew, u4860159
local.contributor.authoruidTrivedi, Shubhanshi, u4585814
local.contributor.authoruidRanasinghe, Charani, u4107621
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor060000 - BIOLOGICAL SCIENCES
local.identifier.ariespublicationU3488905xPUB4890
local.identifier.citationvolume32
local.identifier.doi10.1016/j.vaccine.2014.08.023
local.identifier.scopusID2-s2.0-84908447142
local.identifier.thomsonID000343638200027
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
01_Jackson_Novel_HIV_IL-4R_antagonist_2014.pdf
Size:
2.01 MB
Format:
Adobe Portable Document Format
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS